1ZEO PDB NFT

Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba

IPFS of NFT metadata:

bafybeiasftn3rwt7lxy6tnb3x7ldre66oiohuoyf3kzssylsdewl6p5bay/metadata.json

IPFS of structure file:

bafybeifsirjhk23e7hgdbpn6ta7abo2xqkxfbnnuuuv3tph3awakxnseeq/1zeo.pdb

MOLNFT PDB v1

NFT id:
29632
PDB ID:
1ZEO
Name:
Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist
Keywords:
TRANSCRIPTION
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.50

NFT data

MolNFT PDB v1 is The Protein Data Bank database (URL: https://rcsb.org) of protein structures minted as ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne.
(2000) The Protein Data Bank Nucleic Acids Research, 28: 235-242.

MOLNFT 1ZEO research and analysis (ICN3D with VR)

FASTA sequences

>1zeo_A mol:protein length:277 Peroxisome proliferator activated receptor gamma
GSQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY
>1zeo_B mol:protein length:277 Peroxisome proliferator activated receptor gamma
GSQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY

References and links

Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 1ZEO
TITLE: Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist
DOI: 10.1021/jm0502135
AUTHORS: Shi, G.Q., Dropinski, J.F., McKeever, B.M., Adams, A.D., MacNaul, K.L., Elbrecht, A., Berger, J.P., Zhou, G., Doebber, T.W.
ACCESSION DATE: 04/19/05
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/1ZEO